Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
The stock is up just 8% this year and could prove to be an undervalued buy.
Overview
Leading healthcare company AbbVie (NYSE: ABBV) is coming off a strong quarter. Last month, the Illinois-based business posted yet another round of solid quarterly results, putting on display its robust and diversified healthcare operations.
That wasn't, however, enough to give the stock a boost. And although it has risen in value this year, its gains of 8% trail the market, with the S&P 500 up by 13% thus far in 2026. Could the healthcare stock be a good buy right now?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.